Dissecting the heterogeneity of craniofacial lesions in patients with fibrous dysplasia/ McCune-Albright Syndrome

被引:1
|
作者
Shah, N. [1 ]
Drubach, L. A. [2 ]
Berry, C. [3 ]
Mannstadt, M. [4 ]
Peacock, Z. S. [5 ]
Upadhyay, J. [3 ,6 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA
[2] Harvard Med Sch, Boston Childrens Hosp, Dept Radiol, Boston, MA USA
[3] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA
[4] Harvard Med Sch, Endocrine Unit, Massachusetts Gen Hosp, Boston, MA USA
[5] Massachusetts Gen Hosp, Harvard Sch Dent Med, Dept Oral & Maxillofacial Surg, Boston, MA USA
[6] Harvard Med Sch, McLean Hosp, Dept Psychiat, Belmont, MA USA
关键词
Craniofacial fibrous dysplasia; Positron-emission tomography; Magnetic re- sonance imaging; X-ray computed tomo- graphy; McCune-Albright Syndrome; ACTIVATING MUTATIONS; OPTIC NEUROPATHY; BONE; PROTEIN; SERIES;
D O I
10.1016/j.ijom.2024.08.001
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Fibrous dysplasia/McCune-Albright Syndrome (FD/MAS) frequently involves the craniofacial skeleton. Craniofacial fibrous dysplasia lesions exhibit diverse imaging characteristics on multimodality evaluation, utilizing radiographs, computed tomography (CT), magnetic resonance imaging (MRI), and 18 F-sodium fluoride positron emission tomography (18F-NaF PET). A multimodal imaging classification of craniofacial fibrous dysplasia lesions may offer clinical insights into the types of lesions that are (1) prone to progression, (2) amenable to intervention (i.e., pharmacological or surgical), or (3) associated with symptoms such as pain. In this prospective, preliminary single site study of 15 patients with FD/MAS, the heterogeneity of craniofacial lesions (N = 35) was assessed using a combination of 18 F-NaF PET, MRI, and CT. A k-means clustering algorithm was used to categorize lesions based on imaging characteristics. Clustering analysis revealed three types of lesion based on the magnitude of the regional 18 F-NaF standardized uptake values (SUV), signal intensities on T1-weighted and fluid-sensitive sequences, and appearance on CT (lucent, sclerotic, and/or ground glass). This preliminary study provides a foundation for future longitudinal natural history or treatment studies, where the prognostic value of baseline craniofacial fibrous dysplasia imaging characteristics and clinical symptomatology can be further evaluated.
引用
收藏
页码:1006 / 1014
页数:9
相关论文
共 50 条
  • [21] Expression of RANKL in breast cancer tissue in patients with fibrous dysplasia/McCune-Albright syndrome
    Meier, M. E.
    Hagelstein-Rotman, M.
    Majoor, B. C. J.
    Geels, R. E. S.
    Appelman-Dijkstra, N. M.
    Bravenboer, N.
    BONE, 2023, 169
  • [22] Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives
    Cemre Robinson
    Michael T. Collins
    Alison M. Boyce
    Current Osteoporosis Reports, 2016, 14 : 178 - 186
  • [23] Gynecologic and reproductive outcomes in fibrous dysplasia/McCune-Albright syndrome
    Boyce, Alison M.
    Casey, Rachel K.
    Ovejero Crespo, Diana
    Murdock, Cynthia M.
    Estrada, Andrea
    Guthrie, Lori C.
    Brillante, Beth A.
    Gomez-Lobo, Veronica
    Nieman, Lynette K.
    Collins, Michael T.
    ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
  • [24] Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome
    Lala, Roberto
    Matarazzo, Patrizia
    Andreo, Maria
    Marzari, Daniela
    Bellone, Jaele
    Corrias, Andrea
    de Sanctis, Carlo
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006, 19 : 583 - 593
  • [25] Cutaneous fibrous dysplasia: An incomplete form of the McCune-Albright syndrome
    Schwartz, RA
    Spicer, MS
    Leevy, CB
    Ticker, JB
    Lambert, WC
    DERMATOLOGY, 1996, 192 (03) : 258 - 261
  • [26] Surgical treatment of fibrous dysplasia of bone in McCune-Albright syndrome
    Ippolito, E
    Caterini, R
    Farsetti, P
    Potenza, V
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2002, 15 : 939 - 944
  • [27] Maxillary fibrous dysplasia associated with McCune-Albright syndrome. A case study
    Wojcik, Sylwia
    Koszowski, Rafal
    Drozdowska, Bogna
    Smieszek-Wilczewska, Joanna
    Raczkowska-Siostrzonek, Agnieszka
    OPEN MEDICINE, 2016, 11 (01): : 465 - 470
  • [28] Craniofacial Fibrous Dysplasia Involvements of Mccune-Albright Syn-drome: A Review with an Additional Case
    Ozcan, Ilknur
    Unsal, Gurkan
    Koca, Revan Birke
    Orhan, Kaan
    CURRENT MEDICAL IMAGING, 2021, 17 (07) : 864 - 870
  • [29] Severe Fibrous Dysplasia in McCune-Albright Syndrome: A Need for Continuous Surveillance
    Grob, Francisca
    Clark, Jonathan
    Zacharin, Margaret
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 93 (06): : 402 - 408
  • [30] Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study
    Meier, Maartje E.
    Clerkx, Stance N.
    Winter, Elizabeth M.
    Pereira, Alberto M.
    van de Ven, Annenienke C.
    van de Sande, Michiel A. J.
    Appelman-Dijkstra, Natasha M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (09) : 1729 - 1738